🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase III Randomized Controlled Open Label Comparative Multicentric Trial...
Status
Completed
Location
Indo American Cancer Institute and Research Centre
Start Date
2007-10
Trial ID
NCT00776165
Treatments Being Tested
The purpose of this study is to evaluate the dosages of recombinant human s...
Status
Completed
Location
Cancer Hospital, Chinese Academy of Medical Scienses
Start Date
2014-12-16
Trial ID
NCT02465801
Treatments Being Tested
This pilot phase I trial studies the side effects of total bone marrow and ...
Status
Suspended
Location
City of Hope Medical Center
Start Date
2018-03-19
Trial ID
NCT03467386
This randomized phase III trial studies how well gemcitabine hydrochloride ...
Status
Terminated
Location
Tennessee Valley Gynecologic Oncology
Start Date
2012-06-04
Trial ID
NCT01533207
The overall aim of this study is to determine if epigenetic priming with a ...
Status
Active Not Recruiting
Location
Children's Hospital of Central California
Start Date
2017-06-15
Trial ID
NCT03164057
The purposes of this study are: * To examine the engraftment rate in patie...
Status
Terminated
Location
Children's Healthcare of Atlanta/Emory University
Start Date
2004-04
Trial ID
NCT00228813
Treatments Being Tested
This is an observational study of unstimulated bone marrow (BM) and filgras...
Status
Completed
Location
City of Hope
Start Date
2010-10
Trial ID
NCT01362179
This phase I/II trial studies the best dose and side effects of gemcitabine...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2012-11-21
Trial ID
NCT01629511
The purpose of this study is to examine if it is feasible to administer dec...
Status
Active Not Recruiting
Location
Boston Children's Hospital
Start Date
2023-04-19
Trial ID
NCT05796570
Treatments Being Tested
Randomized phase III trial to compare the effectiveness of interleukin-2 wi...
Status
Completed
Location
Southwest Oncology Group
Start Date
1995-05
Trial ID
NCT00002649